fbpx Skip to main content


WCLC 2021

WCLC 2021 Virtual Newsroom
Janssen Oncology
WCLC 2021 Virtual Newsroom
Janssen Oncology

Welcome to the Janssen Oncology WCLC Virtual Newsroom

At the Janssen Pharmaceutical Companies of Johnson & Johnson, our commitment to patients, caregivers and clinicians goes beyond medicine. Our goals are big. We aim to eliminate cancer. Through our tireless work to advance scientific innovation, address unmet medical needs and improve outcomes for patients – we believe it’s possible.

At the 2021 World Conference on Lung Cancer (WCLC) annual meeting, we will feature multiple presentations in lung cancer, which highlight our efforts to reimagine treatments, to help people live longer and better. We are also dedicated to partnering with the entire care community to provide support beyond our medicines.

We look forward to contributing to important scientific exchange that is foundational to the advancement of patient care. Thank you for visiting Janssen's Virtual Newsroom for WCLC 2021 to learn more about our latest research.

Peter Lebowitz, M.D., Ph.D.
Global Therapeutic Area Head, Oncology
Janssen Research & Development, LLC.

Serge Messerlian
President, Janssen Oncology
Janssen Biotech, Inc.

Latest News


Follow @JanssenGlobal for more news and information during WCLC 2021